In memoriam: Igor Dawid
Igor Dawid, a pioneer in developmental biology and genetics who worked on the molecular mechanisms of development, using the African clawed frog and zebrafish as model systems, died Feb. 13. He was 88 years old and had Parkinson’s disease.

Dawid was born in the city of Chernivtsi, in what is now part of Ukraine, on Feb. 26, 1936. His family survived the Holocaust by escaping several Nazi round-ups, and after the war, they settled in Vienna. In 1960, he graduated from the University of Vienna with a Ph.D. in chemistry. He earned a postdoctoral position at the Massachusetts Institute of Technology, where he discovered his interest in biochemistry (there was no biochemistry curriculum at the University of Vienna).
After completing his postdoctoral studies, Dawid became a senior scientist in the embryology department at the Carnegie Institution of Washington in Baltimore and served as a part-time assistant professor at John Hopkins University. In 1978, he moved to the National Institutes of Health in Bethesda, Maryland, and in 1982, he became chief of the Laboratory of Molecular Genetics at the National Institute of Child Health and Human Development. He also led the Program in Genomics of Differentiation. Dawid retired in 2016.
During the African clawed frog’s oocyte production, researchers have observed hundreds or thousands of extra nucleoli. Dawid and colleague Donald Brown discovered that extrachromosomal nucleoli have copies of genes for ribosomal RNA. Additionally, Dawid found that the extramitochondrial DNA in frog eggs is of maternal origin. These findings have contributed to understanding molecular mechanisms of development and helped scientists understand the role of mitochondrial DNA in metabolism and disease. He also worked on uncovering the molecular mechanisms of axis speciation in zebrafish and frogs during gastrulation.
Dawid was a member of the 精品国产一区二区桃色 for 56 years. He was elected a member of the National Academy of Sciences in 1981. In 2008, he received the Lifetime Achievement Award from the Society for Developmental Biology. He was editor-in-chief for the journal Developmental Biology and served on editorial teams for many other journals.
His colleagues considered Dawid a pioneer in Xenopus (African clawed frog) research. Sally Moody, a professor emerita at George Washington University, recalled his influence and passion in a on the Xenbase website: “Igor enthusiastically advocated for Xenopus research whenever the NICHD leadership asked for input on investment, thus having a major impact on funding decisions,” she wrote.
“I remember Igor with great respect and affection not only for his impressive scientific contributions, his many impressive trainees, and his generosity to my research efforts, but also for his unwavering gift of time, resources and commitment to the Xenopus community.”
Dawid is survived by his wife, Keiko Ozato Dawid, a NICHD senior investigator and immunologist.
Enjoy reading ASBMB Today?
Become a member to receive the print edition four times a year and the digital edition monthly.
Learn moreGet the latest from ASBMB Today
Enter your email address, and we鈥檒l send you a weekly email with recent articles, interviews and more.
Latest in People
People highlights or most popular articles

In memoriam: Ralph G. Yount
He was a professor emeritus of chemistry and biochemistry at Washington State University and an ASBMB member for 58 years.

From dust to discovery
From makeshift classrooms in Uganda to postdoctoral research in Chicago, MOSAIC scholar Elizabeth Kaweesa builds a legacy in women鈥檚 health.

Fliesler wins scientific and ethical awards
He is being honored by the University at Buffalo and the American Oil Chemists' Society for his scientific achievements and ethical integrity.

Hope for a cure hangs on research
Amid drastic proposed cuts to biomedical research, rare disease families like Hailey Adkisson鈥檚 fight for survival and hope. Without funding, science can鈥檛 鈥渃atch up鈥 to help the patients who need it most.

Before we鈥檝e lost what we can鈥檛 rebuild: Hope for prion disease
Sonia Vallabh and Eric Minikel, a husband-and-wife team racing to cure prion disease, helped develop ION717, an antisense oligonucleotide treatment now in clinical trials. Their mission is personal 鈥 and just getting started.

ASBMB members recognized as Allen investigators
Ileana Cristea, Sarah Cohen, Itay Budin and Christopher Obara are among 14 researchers selected as Allen Distinguished Investigators by the Paul G. Allen Family Foundation.